# Eric L. Matteson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-l-matteson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,498 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 110 |
| i10-index | 400 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5052273654 |
| ORCID iD | 0000-0002-9866-0124 |
| Works | 691 |

## Researcher papers

Showing 12 of 15.

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of-2/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/)
- [Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies](https://scholariq.org/papers/anti-tnf-antibody-therapy-in-rheumatoid-arthritis-and-the-risk-of-serious/)
- [2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis](https://scholariq.org/papers/2012-update-of-the-2008-american-college-of-rheumatology-recommendations-for-the/)
- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid-2/)
- [An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features](https://scholariq.org/papers/an-official-european-respiratory-society-american-thoracic-society-research/)
- [Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study](https://scholariq.org/papers/incidence-and-mortality-of-interstitial-lung-disease-in-rheumatoid-arthritis-a/)
- [An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis](https://scholariq.org/papers/an-expansion-of-rare-lineage-intestinal-microbes-characterizes-rheumatoid/)
- [2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative](https://scholariq.org/papers/2012-provisional-classification-criteria-for-polymyalgia-rheumatica-a-european/)
- [The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases](https://scholariq.org/papers/the-lifetime-risk-of-adult-onset-rheumatoid-arthritis-and-other-inflammatory/)
- [<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease](https://scholariq.org/papers/i-muc5b-i-promoter-variant-and-rheumatoid-arthritis-with-interstitial-lung/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.